When choosing a doctor for your breast cancer treatment, use the sources listed below can help you make an informed decision.| Susan G. Komen®
Learn about emerging areas in the treatment of ductal carcinoma in situ (DCIS). DCIS is a non-invasive breast cancer.| Susan G. Komen®
Learn about treatment and prognosis for early breast cancer.| Susan G. Komen®
Invasive Lobular Breast Cancer Watch our Mission Moment webinar, Invasive Lobular Breast Cancer. Read our fact sheet on invasive lobular breast cancer. What is invasive lobular breast cancer? Invasive lobular cancer or infiltrating lobular carcinoma (ILC) is invasive breast cancer that begins in the lobules of the breast. The lobules are small, round sacs in […]| Susan G. Komen®
Learn about the different types of research studies. Review the differences between observational studies and randomized controlled trials.| Susan G. Komen®
Find information for breast cancer patients on clinical trials. Learn about joining a clinical trial and find questions to ask your doctor about clinical trials.| Susan G. Komen®
Learn about chemotherapy as a treatment method for breast cancer here.| Susan G. Komen®
Breast cancer can recur at the original site (called recurrence or local recurrence), as well as return and spread to other parts of the body (called metastasis or distant recurrence).| Susan G. Komen®
Radiation therapy uses targeted, high-energy X-rays to kill breast cancer cells. Also learn about radiation therapy after lumpectomy and after mastectomy.| Susan G. Komen®
Learn how hormone therapies can slow or stop the growth of hormone receptor-positive breast cancer tumors by preventing the cancer cells from getting the hormones they need to grow.| Susan G. Komen®
In this episode of Breast Cancer Breakthroughs, we speak with Komen grantees Dr. Tarah Ballinger, medical oncologist at Indiana University School of Medicine, and Dr. Pedram Razavi, medical oncologist at Memorial Sloan Kettering Cancer Center, about the biggest highlights from the 2024 ASCO Annual Meeting and what they could mean for patients.| Susan G. Komen®